Bryan W. Tillman, Ph.D.

Affiliations: 
2000 University of Alabama, Birmingham, Birmingham, AL, United States 
Google:
"Bryan Tillman"
Mean distance: 22.94 (cluster 59)
 

Parents

Sign in to add mentor
David T. Curiel grad student 2000 UAB
 (CD40 -targeted adenoviral vectors to potentiate dendritic cells for antigen-specific vaccination.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Timares L, Douglas JT, Tillman BW, et al. (2004) Adenovirus-mediated gene delivery to dendritic cells. Methods in Molecular Biology (Clifton, N.J.). 246: 139-54
Stam AG, Santegoets SJ, Westers TM, et al. (2003) CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation. British Journal of Cancer. 89: 1162-5
Brandão JG, Scheper RJ, Lougheed SM, et al. (2003) CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation. Vaccine. 21: 2268-72
de Gruijl TD, Luykx-de Bakker SA, Tillman BW, et al. (2002) Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. Journal of Immunology (Baltimore, Md. : 1950). 169: 5322-31
Barnett BG, Tillman BW, Curiel DT, et al. (2002) Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 377-85
Tillman BW, Hayes TL, DeGruijl TD, et al. (2000) Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Cancer Research. 60: 5456-63
Haisma HJ, Pinedo HM, Rijswijk A, et al. (1999) Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM. Gene Therapy. 6: 1469-74
Tillman BW, de Gruijl TD, Luykx-de Bakker SA, et al. (1999) Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. Journal of Immunology (Baltimore, Md. : 1950). 162: 6378-83
See more...